A slew of National Institutes of Health grant terminations in the spring left affected Northwestern researchers with few ...
One question, in light of FREEDOM, is how well new DES compare with CABG in patients with diabetes and multivessel disease.
VASCEPA was launched in the United States in January 2020 as the first drug approved by the U.S. FDA for treatment ... concomitant antithrombotic medications, such as aspirin, clopidogrel, or warfarin ...
Ticagrelor led to a smaller 30-day cardiac magnetic resonance (CMR)-defined infarct size than clopidogrel in ...
Sucralose, another common sugar substitute, carries its own chilling risks. Some studies suggest that high consumption can ...
Certain medications, such as blood thinners, may interact with omega-3 supplements. Learn more about omega-3 interactions here.
After percutaneous coronary intervention (PCI), dual antiplatelet therapy (DAPT) is recommended for 6 months in stable coronary artery disease1,2 and 12 months in acute coronary syndromes.3,4 Over the ...
In 2015, AI in drug discovery was still a theoretical pursuit – exciting, but unproven. A few early start-ups were applying deep learning to virtual screening and molecular modelling, but the industry ...